Amie J Goodin

Amie J Goodin, Ph.D.

Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 294-8829
Business Email: amie.goodin@cop.ufl.edu

About Amie J Goodin

Dr. Goodin is an Assistant Professor within the Department of Pharmaceutical Outcomes and Policy (POP) and the Center for Drug Evaluation and Safety (CoDES). She received her Master of Public Policy degree from the University of Kentucky (UK). She completed her Doctor of Philosophy degree at UK’s Martin School of Public Policy, with specialization in pharmaceutical outcomes and an additional Certificate in Informatics. She completed a Postdoctoral Fellowship at University of Florida POP, specializing in pharmacoepidemiology methods while continuing her work in Health Services Research. She is the lead for Health Services Research track within POP’s graduate program as well as the faculty lead for Research Strategy within the Consortium for Medical Marijuana Clinical Outcomes Research. Currently, her research projects incorporate mixed-method approaches to assess the impact of policy changes related to treatment access and utilization for Substance Use Disorders, particularly among persons enrolled in Medicaid and pregnant women.

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-0020-8720

Areas of Interest
  • Health Policy
  • Health disparities and vulnerable populations
  • Maternal and Child Health
  • Substance Use Disorders
  • health services research

Publications

2020 Substance abuse treatment, prevention, and policy
2020 The journal of pain : official journal of the American Pain Society
2020 International journal of clinical pharmacology and therapeutics
2018 The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association
2018 American journal of public health
2016 Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
2015 Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Grants

Jan 2020 ACTIVE
Leveraging social media data for evaluation of drug use trends after opioid policies
AMER ASSO OF COL OF PHARMACY ·
Aug 2019 ACTIVE
Program Evaluation and Analytic Support Services for a Substance Use Disorders Recovery Community Center
VOICES OF HOPE · Principal Investigator
Apr 2019 – Apr 2020
Evaluating Learning Outcomes in Continuing Pharmacy and Medical Education
CREATIVE EDUCATIONAL CONCEPTS · Principal Investigator
Mar 2017 – Jun 2020
All-cause readmission measures on inpatient psychiatry facilities
UF HEALTH SHANDS HOSPITAL · Principal Investigator

Education

Ph.D.
2015 · University of Kentucky
M.P.P.
2009 · University of Kentucky
B.S.
2007 · University of Kentucky

Contact Details

Phones:
Business:
(352) 294-8829
Emails:

Recent news

New Florida law leads to decline in opioid use, according to UF study

UF researchers found the number of new opioid users per month dropped 16 percent immediately after Florida House Bill 21 was implemented.

UF Health researchers develop CMS quality measure to evaluate inpatient psychiatric hospitals

The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.

Dr. Amie Goodin featured in NY Times story on the opioid crisis

“Current policies to limit opioid prescriptions leave some pain patients high and dry, resulting in a new wave of unintended consequences for patients with untreated chronic pain.”

We Cannot Treat the Dead

Assistant Scientist Amie Goodin, Ph.D., publishes an editorial in the American Journal of Public Health on the opioid epidemic.